HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1675055Generated: November 3, 2026
Lithium hydroxide, monohydrate → 4-[[1-[3-(Trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-yl]oxy]benzoic acid
https://huagongshe.com/reaction/1675055
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Lithium hydroxide, monohydrate | HCID 168937 | — |
| Reactant | Ethyl 4-[[1-[3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-yl]oxy]benzoate | HCID 67340092 | — |
| Solvent | Methanol | HCID 887 | — |
| Solvent | Water | HCID 962 | — |
| Product | 4-[[1-[3-(Trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-yl]oxy]benzoic acid | HCID 67340503 | 97.2% |
Reaction Steps
Lithium hydroxide monohydrate (0.488 g, 20.40 mmol) was added to ethyl 4-[[1-[3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-yl]oxy]benzoate (2.22 g, 5.10 mmol) in MeOH (80 mL) and water (40.0 mL). The resulting suspension was stirred at 50° C. for 2 days. The reaction was cooled to room temperature, the methanol was evaporated and the aqueous residues treated with citric acid until precipitation ceased. The precipitate was collected by filtration, washed with water and dried to afford 4-[[1-[3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-yl]oxy]benzoic acid (2.020 g, 97%) as a solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08003649B2 |
|---|
| Source dataset | uspto-grants-2011_08 |
|---|
| ORD ID | ord-e65e39f7d2a240499f8a1ce909a675ef |
|---|
| Source note | uspto-grants-2011_08 |
|---|